Fighting Virus Pandemics: The Now and The Future - Expert’s Perception of Challenges & Opportunities

Feb 27 2020

Moderator:

• Echo Hindle-Yang, CEO at MSQ

Invited guests:

• Ms. Ping Wang Rawson, CFO at Dyadic International

• Dr. Shawn Shi, Venture Partner at MSQ

About Dyadic International

Dyadic International, Inc. (NASDAQ: DYAI) is a global biotechnology company focused on further improving and leveraging the patented and proprietary C1 expression system to help bring biologic vaccines and drugs to market faster, in greater volumes, at lower cost, and with new properties to drug developers and manufacturers to improve access and cost to patients and the healthcare system – but most importantly to save lives.